Published in Antimicrob Agents Chemother on January 01, 2002
Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis. Antimicrob Agents Chemother (2009) 0.90
Inhibition of chlamydial infection in the genital tract of female mice by topical application of a peptide deformylase inhibitor. Microbiol Res (2007) 0.88
The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis. J Antimicrob Chemother (2008) 0.86
LHRH-conjugated lytic peptides directly target prostate cancer cells. Biochem Pharmacol (2010) 0.85
Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing. Antimicrob Agents Chemother (2009) 0.79
Susceptibility of Chlamydia trachomatis to excipients commonly used in topical microbicide formulations. Antimicrob Agents Chemother (2004) 0.78
Biosynthesized tea polyphenols inactivate Chlamydia trachomatis in vitro. Antimicrob Agents Chemother (2005) 0.76
Natural Products for the Treatment of Chlamydiaceae Infections. Microorganisms (2016) 0.75
Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides. Pharmaceuticals (Basel) (2016) 0.75
Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS (1993) 10.84
Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J Membr Biol (1997) 2.80
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.41
Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect Immun (1996) 2.16
Challenges for the development of female-controlled vaginal microbicides. AIDS (1994) 1.97
A new fluorometric assay for cytotoxicity measurements in-vitro. Int J Oncol (1993) 1.96
Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun (1997) 1.75
Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotechnol Lab (1993) 1.66
Sulfated carbohydrate compounds prevent microbial adherence by sexually transmitted disease pathogens. Antimicrob Agents Chemother (1997) 1.46
Structure-function relationships of antimicrobial peptides. Biochem Cell Biol (1998) 1.44
Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J Gen Virol (1998) 1.36
Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). Am J Obstet Gynecol (1999) 1.34
Killing of Chlamydia trachomatis by novel antimicrobial lipids adapted from compounds in human breast milk. Antimicrob Agents Chemother (1998) 1.32
Antimicrobial activity of cecropins. J Antimicrob Chemother (1996) 1.31
Cell-lytic and antibacterial peptides that act by perturbing the barrier function of membranes: facets of their conformational features, structure-function correlations and membrane-perturbing abilities. Biochim Biophys Acta (1994) 1.29
Gene-encoded peptide antibiotics and the concept of innate immunity: an update review. Scand J Immunol (1998) 1.29
Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS (1998) 1.28
In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides. Antimicrob Agents Chemother (1998) 1.26
Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar. Clin Infect Dis (1994) 1.24
Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture. Antimicrob Agents Chemother (1986) 1.23
Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma. Gut (1990) 1.22
Clinical features of Chlamydia trachomatis rectal infection by serovar among homosexually active men. Sex Transm Dis (1999) 1.21
Susceptibility of Chlamydia trachomatis to chlorhexidine gluconate gel. Antimicrob Agents Chemother (1998) 1.16
ABC of colorectal diseases. Sexually transmitted diseases and anal papillomas. BMJ (1992) 1.11
Reducing the risk of Chlamydia trachomatis genital tract infection by evaluating the prophylactic potential of vaginally applied chemicals. Clin Infect Dis (1995) 1.07
Mucosal surface pH of the large intestine of the rat and of normal and inflamed large intestine in man. Gut (1987) 1.03
In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria. Antimicrob Agents Chemother (1998) 0.99
Anal warts, sexually transmitted diseases, and anorectal conditions associated with human immunodeficiency virus. Prim Care (1999) 0.90
Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9. Sex Transm Dis (1999) 0.89
Sexually transmitted diseases of the colon, rectum, and anus. The challenge of the nineties. Dis Colon Rectum (1990) 0.87
Priorities for vaginal microbicide research. Am J Public Health (1995) 0.78
Chlamydia trachomatis infections in the female rectums. Genitourin Med (1989) 0.77
Isolation of Chlamydia trachomatis from the lower digestive tract. Infection (1994) 0.77
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med (1996) 11.91
Diagnosis of coliform infection in acutely dysuric women. N Engl J Med (1982) 8.75
Nosocomial acquisition of Clostridium difficile infection. N Engl J Med (1989) 7.72
Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet (1995) 7.46
Causes of the acute urethral syndrome in women. N Engl J Med (1980) 6.91
Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J Infect Dis (1985) 6.32
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis (1999) 5.99
Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol (1983) 5.70
Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am (1997) 5.27
Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1994) 5.15
Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA (1986) 4.93
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA (1999) 4.69
A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med (1996) 4.69
Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med (1993) 4.54
Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine. J Clin Microbiol (1993) 4.50
Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 4.20
Microtest procedure for isolation of Chlamydia trachomatis. J Clin Microbiol (1981) 4.14
Urinary tract infections in women: diagnosis and treatment. Ann Intern Med (1989) 3.97
Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93
Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med (2001) 3.92
Lack of circumcision increases the risk of urinary tract infection in young men. JAMA (1992) 3.90
Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis (2000) 3.86
Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. J Clin Microbiol (1993) 3.82
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med (1993) 3.18
Diagnosis of Chlamydia trachomatis infections by direct immunofluorescence staining of genital secretions. A multicenter trial. Ann Intern Med (1984) 3.15
The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12
Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02
Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med (1984) 2.89
Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med (2001) 2.83
A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med (2000) 2.81
Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis (1992) 2.80
Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA (1995) 2.75
Sexually transmitted diseases in victims of rape. N Engl J Med (1990) 2.74
Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections. J Infect Dis (1987) 2.66
Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65
Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis (2000) 2.64
Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection. JAMA (1993) 2.63
Risk factors for recurrent urinary tract infection in young women. J Infect Dis (2000) 2.48
Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med (1984) 2.44
Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol (1994) 2.41
Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol (1990) 2.36
Prevalence and characterization of hippurate-negative Campylobacter jejuni in King County, Washington. J Clin Microbiol (1987) 2.33
Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis (2001) 2.24
Use of sequential enzyme immunoassay and direct fluorescent antibody tests for detection of Chlamydia trachomatis infections in women. J Clin Microbiol (1990) 2.22
Measurement of pyuria and its relation to bacteriuria. Am J Med (1983) 2.19
Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis (1990) 2.17
Nucleotide sequence of the variable domains within the major outer membrane protein gene from serovariants of Chlamydia trachomatis. Infect Immun (1993) 2.15
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13
Simplified microtiter cell culture method for rapid immunotyping of Chlamydia trachomatis. J Clin Microbiol (1991) 2.11
Chlamydial infections. What should we do while waiting for a diagnostic test? West J Med (1981) 2.11
Staining characteristics of six commercially available monoclonal immunofluorescence reagents for direct diagnosis of Chlamydia trachomatis infections. J Clin Microbiol (1988) 2.10
Campylobacter cinaedi is normal intestinal flora in hamsters. J Clin Microbiol (1989) 2.09
Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands. Genitourin Med (1988) 2.07
Bacteremia caused by Campylobacter-like organisms in two male homosexuals. Ann Intern Med (1984) 2.07
In vitro response of Enterobacter to ampicillin. Antimicrob Agents Chemother (1979) 2.06
Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol (1993) 2.06
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Monoclonal antibodies for diagnosis of infectious diseases in humans. Science (1983) 2.02
Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med (1979) 1.94
Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun (1988) 1.93
Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis (1998) 1.92
Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis (1976) 1.92
Sexually transmitted diseases in females in a juvenile detention center. Sex Transm Dis (1985) 1.91
Pseudoepidemics in hospital. Lancet (1977) 1.89
In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents. Antimicrob Agents Chemother (1985) 1.88
Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol (1990) 1.88
Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J Infect Dis (1995) 1.87
Prevalence of Mycoplasma genitalium determined by DNA probe in men with urethritis. Lancet (1988) 1.86
Isolation of "Campylobacter hyointestinalis" from a human. J Clin Microbiol (1986) 1.85
"Campylobacter cinaedi" bacteremia: case report and laboratory findings. J Clin Microbiol (1987) 1.83
Use of a urine enzyme immunoassay as a diagnostic tool for Chlamydia trachomatis urethritis in men. J Clin Microbiol (1991) 1.81
Rapid immunotyping of Chlamydia trachomatis with monoclonal antibodies in a solid-phase enzyme immunoassay. J Clin Microbiol (1985) 1.79
Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect Immun (2000) 1.78
Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology. JAMA (1984) 1.77
Genetic and physical organization of the cloned gyrA and gyrB genes of Bacillus subtilis. J Bacteriol (1985) 1.77
Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates. Infect Immun (1998) 1.75
Association of carboxylesterase B electrophoretic pattern with presence and expression of urovirulence factor determinants and antimicrobial resistance among strains of Escherichia coli that cause urosepsis. Infect Immun (1991) 1.73
Etiology of cervical inflammation. Am J Obstet Gynecol (1986) 1.72
Intestinal spirochetosis in homosexual men. Am J Med (1987) 1.72
Treatment of the acute urethral syndrome. N Engl J Med (1981) 1.71
Escherichia coli bacteriuria and contraceptive method. JAMA (1991) 1.71
Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 1.71
Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA (1985) 1.66
Urinary-tract infection in sexually active homosexual men. Lancet (1986) 1.66
Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect (2005) 1.65
Relationship of early readings of minimal inhibitory concentrations to the results of overnight tests. Antimicrob Agents Chemother (1975) 1.65
CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc Natl Acad Sci U S A (2001) 1.64
Adequacy of fellowship training: results of a survey of recently graduated fellows. Clin Infect Dis (2001) 1.63
O, K, and H antigens predict virulence factors, carboxylesterase B pattern, antimicrobial resistance, and host compromise among Escherichia coli strains causing urosepsis. J Infect Dis (1994) 1.62
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro. Antimicrob Agents Chemother (2009) 1.62
Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med (1980) 1.61
Detection of multiple serovars of Chlamydia trachomatis in genital infections. J Infect Dis (1985) 1.61
Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med (1997) 1.60
Successive bacteremias with "Campylobacter cinaedi" and "Campylobacter fennelliae" in a bisexual male. J Clin Microbiol (1987) 1.60
Indwelling arterial catheters as a source of nosocomial bacteremia. An outbreak caused by Flavobacterium Species. N Engl J Med (1975) 1.59